Ickrath et al. reported that CD4+ T cells from the nasal polyps of patients with ECRS exhibited a surface CD69 expression of 38.25% ± 14.23%; however, this expression was not detected in peripheral blood T cells [29]. The gene discussed is CD69; the disease is nasal cavity polyp.